Leaflet FIBROVEIN 3% solution for injection

Indicated for: varicose veins; venous sclerotherapy

Route of administration: injectable

Substance: sodium tetradecyl sulfate (sclerosing agent)

ATC: C05BB04 (Cardiovascular system | Antivaricose therapy | Sclerosing agents for local injection)

Precautions:
Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Sodium tetradecyl sulfate is a sclerosing agent used in the treatment of varicose veins and reticular veins. It works by irritating the venous wall, causing the vein to collapse and close.

The medication is administered as an injection directly into the affected vein, as directed by a doctor. It is important for the procedure to be performed by a specialist to minimize risks.

Patients should be aware of potential side effects, such as local pain, inflammation, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local pain, inflammation, and skin discoloration. In rare cases, severe reactions such as deep vein thrombosis or anaphylactic reactions may occur. Patients should be informed of these risks before treatment.

General data about FIBROVEIN 3%

  • Substance: sodium tetradecyl sulfate
  • Date of latest medicines list: 01-06-2026
  • Product code: W67006001
  • Concentration: 3%
  • Pharmaceutical form: solution for injection
  • Quantity: 5
  • Product type: Generic medicine
  • Price: 259.47 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: MEDIPHA SANTE - FRANTA
  • Holder: STD PHARMACEUTICAL (IRELAND) LIMITED - IRLANDA
  • Number: 10790/2018/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Concentrations available for sodium tetradecyl sulfate

  • 0.2%
  • 0.5%
  • 1%
  • 3%